Ambit Biosciences
Develops small molecule kinase inhibitors for cancer and inflammatory disease treatments. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
$410m (Public information from Sep 2014)
San Diego California (HQ)
Authorizing premium user...